Brochure
All Offerings
Summary: Catalyst + Talent. Our name combines these ideas. From drug and biologic development to delivery technologies and supply solutions, we are the catalyst for your...
View Now
Offering Fact Sheet
Regulatory Support
Summary: Our regulatory team completes over 150 agency submissions each year, supporting all stages of the product lifecycle. We assign a dedicated...
View Now
Video
Catalent: Softgel Encapsulation
Summary: Softgel technology is the commercially-proven choice for encapsulation of challenging compounds. In addition, softgel technology may enhance the bioavailability of your product to...
View Now
Video
Improving Bioavailability with Softgel Technology
Summary: Softgel technology offers a number of technical benefits. Probably foremost is the improvement or enhanced bioavailability that's often achievable with the Softgel dosage...
View Now
Video
RP Scherer Softgel Technology for Superior Drug Delivery
Summary: As innovators of softgel technology, Catalent RP Scherer softgel brings more than 75 years of development expertise and manufacturing experience to the full spectrum of drug delivery...
View Now
Presentation
CDMO Playbook for Consultants: Preparing Your Clients for Success with Tips and Strategies to Avoid Common Mistakes
Summary: Determining a client’s primary goal is critical to guiding them through the development of their asset. Three experienced industry colleagues recently presented on the latest tips...
View Now
Video
RP Scherer Softgel Technology | Why Catalent?
Summary: As innovators of softgel technology, Catalent RP Scherer softgel, brings more than 75 years of development expertise and manufacturing experience to the full spectrum...
View Now
Video
RP Scherer Softgel Heritage | Why Catalent?
Summary: As innovators of softgel technology, Catalent RP Scherer softgel brings more than 75 years of development expertise and manufacturing experience to the full spectrum of drug...
View Now
Video
Reliably Supplied | Why Catalent?
Summary: We have the technology and expertise to take your product from design, to clinical trial, to plant, to pharmacy. Our global network of facilities can provide scalable, cost-effective...
View Now
Video
Softgel Technology to Deliver Poorly Soluble APIs | Catalent in 90 Seconds
Summary: The number of poorly soluble new drugs entering development has been estimated to be anywhere from 40% to 70%. Many companies are increasingly focusing their attention on the properties...
View Now